Invention Grant
US09249227B2 Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
有权
使用semaphorin-4D结合分子治疗神经变性疾病
- Patent Title: Use of semaphorin-4D binding molecules for treating neurodegenerative disorders
- Patent Title (中): 使用semaphorin-4D结合分子治疗神经变性疾病
-
Application No.: US14753882Application Date: 2015-06-29
-
Publication No.: US09249227B2Publication Date: 2016-02-02
- Inventor: Ernest S. Smith , Maurice Zauderer , William J. Bowers , Alan Jonason
- Applicant: Vaccinex, Inc.
- Applicant Address: US NY Rochester
- Assignee: Vaccinex, Inc.
- Current Assignee: Vaccinex, Inc.
- Current Assignee Address: US NY Rochester
- Agency: Thompson Coburn LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K39/395 ; A61K45/06 ; A61K39/00
Abstract:
Provided herein are methods for alleviating symptoms in a subject having a neurodegenerative disorder, comprising administering to the subject an effective amount of an isolated binding molecule which specifically binds to semaphorin-4D (SEMA4D) or to its Plexin-B1 or Plexin-B2 receptors.
Public/Granted literature
- US20150353641A1 USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATIVE DISORDERS Public/Granted day:2015-12-10
Information query
